MODERATOR
:
SPEAKER
(S):
Barbee Whitaker, PhD, Director, Research and AABB Center for Patient Safety, AABB
Beverly Collins, MT(ASCP)SBB, Quality Supervisor, University of Texas Medical Branch at Galveston
Matthew Kuehnert, MD, Director, Office of Blood, Organ, Other Tissue Safety, Centers for Disease Control and Prevention
Nanci Fredrich, RN, BSN, MM, Transfusion Safety & Blood Management Officer, BloodCenter of Wisconsin
Dr. Mary Townsend, MD, Senior Medical Director, Blood Systems, Inc.
Description
This session will include an overview of US biovigilance activities to date and those in development and an opportunity to hear reports from the experiences of individual hospitals and blood centers that have implemented hemovigilance locally.
LEARNER OUTCOMES:
-
Describe biovigilance and the systems that are in place or in progress to achieve biovigilance in the US.
-
Describe how transfusion safety officers can support hemovigilance activities.
-
List an intervention that has been implemented based on the use of hemovigilance data.
-
List benefits for hospitals to participate in the Hemovigilance Module of the National Healthcare Safety Network.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.